New heart valve offers hope for patients with severe leaky heart
Disease control
Not yet recruiting
This early study tests a new device called the TRICENTO G2 to treat severe tricuspid regurgitation, a condition where a heart valve leaks badly. Ten adults with symptoms like shortness of breath or swelling will get the valve through a minimally invasive procedure. The goal is to…
Phase: NA • Sponsor: Medira GmbH • Aim: Disease control
Last updated Jun 27, 2026 12:09 UTC